Direct Meds vs DrMedHealth

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Direct Meds

Affiliate partner

Needle-averse shoppers who want a sublingual route on either molecule and will pay above the going rate for it, having accepted a three-month supply as the smallest unit sold.

Semaglutide / month: $249/moSublingual, 90-day supply billed monthly
Tirzepatide / month: $299/moSublingual, 90-day supply billed monthly

Index 71/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Direct Meds pricing Read review

DrMedHealth

Provider comparison

DrMedHealth's site is now a set of AI health-information tools. It doesn't prescribe or sell GLP-1 medication.

Semaglutide / month: $199/moAll doses, compounded oral
Tirzepatide / month: $299/moAll doses, compounded oral

Unavailable · Not scoredChecked October 2026

DrMedHealth's site is now a set of AI health-information tools. It doesn't prescribe or sell GLP-1 medication.

Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

This pair includes a provider that is unavailable for direct GLP-1 enrollment. We do not declare a score winner or compare factor scores when either provider is unavailable.

DrMedHealth: DrMedHealth's site is now a set of AI health-information tools. It doesn't prescribe or sell GLP-1 medication.

Check the difference in state access

Direct Meds: Not disclosed
DrMedHealth: Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Direct Meds

DrMedHealth

Semaglutide / month: Direct Meds: $249/moSublingual, 90-day supply billed monthly; DrMedHealth: $199/moAll doses, compounded oral

Tirzepatide / month: Direct Meds: $299/moSublingual, 90-day supply billed monthly; DrMedHealth: $299/moAll doses, compounded oral

Semaglutide / year (modeled): Direct Meds: $2,988; DrMedHealth: $2,388

Tirzepatide / year (modeled): Direct Meds: $3,588; DrMedHealth: $3,588

State availability: Direct Meds: Not disclosed; DrMedHealth: Coverage not published

Oral / sublingual option listed: Direct Meds: Yes; DrMedHealth: Yes

Brand-name access listed: Direct Meds: Not confirmed; DrMedHealth: Yes

Provider facts checked: Direct Meds: October 2026; DrMedHealth: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

Review the access limitations and recorded program details. Availability comes before choosing a treatment plan.

Direct Meds

Needle-averse shoppers who want a sublingual route on either molecule and will pay above the going rate for it, having accepted a three-month supply as the smallest unit sold.

Reasons to consider it

Sublingual and injection on both molecules, so four GLP-1 products to choose from
Every price is published per SKU in a public shop, with no quiz, intake or email capture in front of it
Each product page prints a per-day equivalent beside the monthly rate ($8.03/day at $249), which is unusually concrete for this category

What to weigh up

$249 a month for the sublingual and $297 for the injection cost more than many programs we track charge for an injection
The only purchasable option on every product page is a 90-DAY SUPPLY billed monthly, so three months is the smallest unit sold — there is no month-to-month rate to compare with programs you can cancel after one month
Every headline figure is framed "AS LOW AS", yet the only available option shows "0% OFF" — the framing implies a cheaper tier that is not actually on sale

Regulatory note: the FDA issued a warning letter to directmeds.com, Inc. dba DirectMeds in September 2025. We still list and link to Direct Meds; you should know the letter is on the public record before you decide.

Compounded drugs are not FDA-approved. Understand the medication options.

Check Direct Meds pricing Read the full Direct Meds review

DrMedHealth

DrMedHealth's site is now a set of AI health-information tools. It doesn't prescribe or sell GLP-1 medication.

Provider background

Flat pricing regardless of dose -- no hidden dose-escalation cost
Both injectable and oral forms offered for each drug
LegitScript certified with nationwide (50 states + DC) coverage

What to weigh up

No single named medical director, just a list of prescribing providers
Shares 'CareGLP' backend infrastructure with other sites, so clinical independence is unclear
$199-299/month oral options are new/less-studied delivery forms vs. standard injectable GLP-1s

Regulatory note: the FDA issued a warning letter to Public Health Solution LLC dba DrMedHealth in June 2026. We still list and link to DrMedHealth; you should know the letter is on the public record before you decide.

DrMedHealth's site is now a set of AI health-information tools. It doesn't prescribe or sell GLP-1 medication.

Read the full DrMedHealth review

Before you sign up

Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to Direct Meds Alternatives to DrMedHealth

More provider matchups

CoreAge Rx vs Direct Meds CoreAge Rx vs DrMedHealth

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.